Level C· Early human research exploring benefitsProspective StudyPubMedOpen access

Stem cell therapy prior to follicular unit hair transplantation on scarred tissue: a novel approach to a successful procedure.

Popescu FM., Filip L., Popescu M., Florescu IP.

Prospective Study with a reported sample of 30 on Scar, Hair Loss, Hair Regeneration, published in J Med Life (2024) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
J Med Life (2024)
Country
Romania
Reported sample size
30
Source database
PubMed
PMID
39296433
PMCID
PMC11407486
DOI
10.25122/jml-2024-0303
Citations
3

Abstract (original English)

Follicular unit hair extraction (FUE) is effective for hair restoration but is less successful on scarred tissue due to reduced vascularity and altered tissue architecture. Stem cell therapy can enhance tissue regeneration, possibly improving FUE outcomes on scarred tissue. This study investigated the impact of stem cell therapy prior to FUE on scarred tissue. Sixty patients with scalp scars from trauma or previous surgeries were divided into two groups. Group A ( n = 30) received autologous stem cell therapy followed by FUE, while Group B ( n = 30) underwent FUE without prior stem cell treatment. Autologous stem cells were harvested from patients' adipose tissue and injected into the scarred area four weeks before FUE. Outcomes were assessed at 3-, 6-, and 12-months post-transplantation, focusing on hair density, graft survival rate, and patient satisfaction. Histological examinations evaluated tissue regeneration. Group A showed significantly higher hair density (mean increase of 45%) and graft survival rates (87%) compared to Group B (mean increase of 25%, graft survival rate of 60%) at all follow-up points ( P < 0.05). Histological analysis revealed enhanced neovascularization and reduced fibrosis in the stem cell-treated group, with 70% more new blood vessels and 50% less fibrotic tissue compared to the control group. Patient satisfaction scores were higher in Group A (ave

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansCicatrixHair FollicleFemaleAdultStem Cell TransplantationMaleMiddle AgedTransplantation, AutologousAlopecia

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research